<!DOCTYPE html>
<html lang="zh-CN">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="chapt 11.7 èŒ‰è‰é…¸  ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š èŒ‰è‰é…¸ç±» (Jasmonates, JAs): ä¸€ç±»æºè‡ªæ¸¸ç¦»è„‚è‚ªé…¸ï¼ˆå¦‚äºšéº»é…¸ï¼‰æ°§åŒ–çš„æ°§åŒ–è„‚ç±» (Oxylipins) æ¤ç‰©æ¿€ç´ ã€‚åŒ…æ‹¬èŒ‰è‰é…¸ (JA)ã€èŒ‰è‰é…¸ç”²é…¯ (MeJA) å’Œæ´»æ€§å½¢å¼èŒ‰è‰é…¸-å¼‚äº®æ°¨é…¸ (JA-Ile)ã€‚å®ƒä»¬åœ¨é˜²å¾¡æ˜†è™«å’Œæ­»ä½“è¥å…»å‹...">
    <meta name="keywords" content="æ¤ç‰©ç”Ÿç†å­¦/ååŠ, chapt 11.7 èŒ‰è‰é…¸">
    <meta name="author" content="Yukari502">
    <meta name="article-slug" content="chapt-117-èŒ‰è‰é…¸">
    <meta name="root-path" content="../../">

    <!-- Open Graph / Facebook -->
    <meta property="og:type" content="article">
    <meta property="og:url" content="https://yukari502.github.io/posts/æ¤ç‰©ç”Ÿç†å­¦ååŠ/chapt-117-èŒ‰è‰é…¸.html">
    <meta property="og:title" content="chapt 11.7 èŒ‰è‰é…¸">
    <meta property="og:description" content="chapt 11.7 èŒ‰è‰é…¸  ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š èŒ‰è‰é…¸ç±» (Jasmonates, JAs): ä¸€ç±»æºè‡ªæ¸¸ç¦»è„‚è‚ªé…¸ï¼ˆå¦‚äºšéº»é…¸ï¼‰æ°§åŒ–çš„æ°§åŒ–è„‚ç±» (Oxylipins) æ¤ç‰©æ¿€ç´ ã€‚åŒ…æ‹¬èŒ‰è‰é…¸ (JA)ã€èŒ‰è‰é…¸ç”²é…¯ (MeJA) å’Œæ´»æ€§å½¢å¼èŒ‰è‰é…¸-å¼‚äº®æ°¨é…¸ (JA-Ile)ã€‚å®ƒä»¬åœ¨é˜²å¾¡æ˜†è™«å’Œæ­»ä½“è¥å…»å‹...">
    <meta property="og:site_name" content="Digital Garden">

    <!-- Twitter -->
    <meta property="twitter:card" content="summary_large_image">
    <meta property="twitter:url" content="https://yukari502.github.io/posts/æ¤ç‰©ç”Ÿç†å­¦ååŠ/chapt-117-èŒ‰è‰é…¸.html">
    <meta property="twitter:title" content="chapt 11.7 èŒ‰è‰é…¸">
    <meta property="twitter:description" content="chapt 11.7 èŒ‰è‰é…¸  ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š èŒ‰è‰é…¸ç±» (Jasmonates, JAs): ä¸€ç±»æºè‡ªæ¸¸ç¦»è„‚è‚ªé…¸ï¼ˆå¦‚äºšéº»é…¸ï¼‰æ°§åŒ–çš„æ°§åŒ–è„‚ç±» (Oxylipins) æ¤ç‰©æ¿€ç´ ã€‚åŒ…æ‹¬èŒ‰è‰é…¸ (JA)ã€èŒ‰è‰é…¸ç”²é…¯ (MeJA) å’Œæ´»æ€§å½¢å¼èŒ‰è‰é…¸-å¼‚äº®æ°¨é…¸ (JA-Ile)ã€‚å®ƒä»¬åœ¨é˜²å¾¡æ˜†è™«å’Œæ­»ä½“è¥å…»å‹...">

    <title>chapt 11.7 èŒ‰è‰é…¸ - D.RAY</title>

    <!-- Google Fonts -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Outfit:wght@300;400;500;600;700&family=JetBrains+Mono:wght@400;500&display=swap"
        rel="stylesheet">

    <!-- Highlight.js -->
    <link rel="stylesheet"
        href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/11.9.0/styles/atom-one-dark.min.css">
    <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/11.9.0/highlight.min.js"></script>

    <!-- KaTeX -->
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.css">
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.js"></script>
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/contrib/auto-render.min.js"></script>

    <!-- Marked.js for Markdown parsing -->
    <script src="https://cdn.jsdelivr.net/npm/marked/marked.min.js"></script>

    <!-- Mermaid.js for diagrams and flowcharts -->
    <script type="module">
        import mermaid from 'https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.esm.min.mjs';
        mermaid.initialize({
            startOnLoad: false,
            theme: 'dark',
            themeVariables: {
                primaryColor: '#8b5cf6',
                primaryTextColor: '#fff',
                primaryBorderColor: '#7c3aed',
                lineColor: '#a78bfa',
                secondaryColor: '#6d28d9',
                tertiaryColor: '#5b21b6'
            }
        });
        window.mermaid = mermaid;
    </script>

    <!-- Custom Styles -->
    <link rel="stylesheet" href="../../style.css">
    <link rel="icon" href="../../ico/favicon.ico" type="image/x-icon">

    <style>
        .article-page {
            max-width: 1150px;
            margin: 0 auto;
            padding: 2rem;
        }

        .article-header {
            margin-bottom: 3rem;
            padding-bottom: 2rem;
            border-bottom: 2px solid var(--border-color);
        }

        .article-title {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 1rem;
            line-height: 1.2;
        }

        .article-meta {
            display: flex;
            gap: 1rem;
            color: var(--text-secondary);
            font-size: 0.95rem;
        }

        .article-meta span {
            display: flex;
            align-items: center;
            gap: 0.3rem;
        }

        .back-link {
            display: inline-flex;
            align-items: center;
            gap: 0.5rem;
            color: var(--accent-color);
            text-decoration: none;
            margin-bottom: 2rem;
            font-weight: 500;
            transition: transform 0.2s;
        }

        .back-link:hover {
            transform: translateX(-4px);
        }

        .article-content {
            font-size: 1.1rem;
            line-height: 1.8;
        }

        @media (max-width: 768px) {
            .article-page {
                padding: 1rem;
            }

            .article-title {
                font-size: 2rem;
            }
        }

        .article-footer {
            margin-top: 4rem;
            padding-top: 2rem;
            border-top: 1px solid var(--border-color);
            text-align: center;
            color: var(--text-secondary);
            font-size: 0.85rem;
        }

        .article-footer .disclaimer {
            font-size: 0.75rem;
            margin-top: 0.5rem;
            font-style: italic;
            opacity: 0.8;
        }
    </style>
    <meta name="build-hash" content="14dfaa39addee0721732d51e5201d7be">
</head>

<body>
    <div class="article-page">
        <a href="../../" class="back-link">
            <svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none"
                stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <line x1="19" y1="12" x2="5" y2="12"></line>
                <polyline points="12 19 5 12 12 5"></polyline>
            </svg>
            è¿”å›ä¸»é¡µ
        </a>

        <div class="article-header">
            <h1 class="article-title">chapt 11.7 èŒ‰è‰é…¸</h1>
            <div class="article-meta">
                <span>ğŸ“… 2026-01-14</span>
                <span>ğŸ“‚ æ¤ç‰©ç”Ÿç†å­¦/ååŠ</span>
            </div>
        </div>

        <article class="article-content markdown-body" id="article-content">
            <!-- Content will be rendered here -->
        </article>

        <!-- Store markdown content in a script tag -->
        <script type="text/markdown" id="markdown-source">
# chapt 11.7 èŒ‰è‰é…¸

## ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š

**èŒ‰è‰é…¸ç±» (Jasmonates, JAs):** ä¸€ç±»æºè‡ªæ¸¸ç¦»è„‚è‚ªé…¸ï¼ˆå¦‚äºšéº»é…¸ï¼‰æ°§åŒ–çš„**æ°§åŒ–è„‚ç±» (Oxylipins)** æ¤ç‰©æ¿€ç´ ã€‚åŒ…æ‹¬èŒ‰è‰é…¸ (JA)ã€èŒ‰è‰é…¸ç”²é…¯ (MeJA) å’Œæ´»æ€§å½¢å¼èŒ‰è‰é…¸-å¼‚äº®æ°¨é…¸ (JA-Ile)ã€‚å®ƒä»¬åœ¨é˜²å¾¡æ˜†è™«å’Œæ­»ä½“è¥å…»å‹ç—…åŸèŒä»¥åŠè°ƒæ§æ¤ç‰©å‘è‚²ä¸­èµ·å…³é”®ä½œç”¨ã€‚


**æ­»ä½“è¥å…»å‹ç—…åŸèŒ (Necrotrophic pathogens, N):** é€šè¿‡æ€æ­»æ¤ç‰©ç»†èƒå¹¶ä»¥å…¶æ­»äº¡ç»„ç»‡ä¸ºé£Ÿçš„ç—…åŸèŒï¼ˆå¦‚ *Alternaria brassicicola*, *Botrytis cinerea*ï¼‰ã€‚è¿™ç±»ç—…åŸèŒçš„ä¾µæŸ“é€šå¸¸è¯±å¯¼æ¤ç‰©äº§ç”ŸèŒ‰è‰é…¸ (JA) è¿›è¡Œé˜²å¾¡ï¼ŒåŒºåˆ«äºæ´»ä½“è¥å…»å‹ç—…åŸèŒï¼ˆè¯±å¯¼æ°´æ¨é…¸ SAï¼‰ã€‚



### äºŒã€ æ¤ç‰©ç”Ÿç†å­¦é‡ç‚¹å†…å®¹å½’çº³

**1. ç”Ÿç‰©åˆæˆä¸ä»£è°¢ (Biosynthesis and Metabolism)**
*   **åˆæˆéƒ¨ä½ä¸è·¯å¾„ï¼š** è·¨è¶Šä¸‰ä¸ªç»†èƒå™¨ã€‚
    1.  **è´¨ä½“ (Plastid):** è†œè„‚ä¸­çš„ $\alpha$-äºšéº»é…¸ (18:3) åœ¨ **LOX** (è„‚æ°§åˆé…¶), **AOS**, **AOC** ä½œç”¨ä¸‹è½¬åŒ–ä¸º OPDAã€‚
    2.  **è¿‡æ°§åŒ–ç‰©é…¶ä½“ (Peroxisome):** OPDA è¢« **OPR3** è¿˜åŸï¼Œç» $\beta$-æ°§åŒ–ç”Ÿæˆ **JA**ã€‚
    3.  **ç»†èƒè´¨ (Cytosol):** JA ç» **JAR1** å‚¬åŒ–ä¸å¼‚äº®æ°¨é…¸ç»“åˆç”Ÿæˆæ´»æ€§å½¢å¼ **JA-Ile**ï¼›æˆ–ç» **JMT** è½¬åŒ–ä¸ºæŒ¥å‘æ€§çš„ **MeJA**ã€‚
*   **ä»£è°¢å¤±æ´»ï¼š** ç»†èƒè‰²ç´  P450 é…¶ (**CYP94B3**) è´Ÿè´£å°† JA-Ile ç¾ŸåŸºåŒ–ï¼ˆ12OH-JA-Ileï¼‰ä½¿å…¶å¤±æ´»ï¼Œè¿™å¯¹äºé˜²æ­¢è¿‡åº¦é˜²å¾¡ååº”è‡³å…³é‡è¦ã€‚

**2. ç”Ÿç†åŠŸèƒ½ (Physiological Functions)**
*   **é˜²å¾¡ååº” (Defense):**
    *   ä¸»è¦é˜²å¾¡ **é£Ÿè‰æ˜†è™« (Insects)**ï¼ˆå¦‚æ£‰é“ƒè±¡ç”²ã€å¶ç”²ï¼‰å’Œ **æ­»ä½“è¥å…»å‹ç—…åŸèŒ (Necrotrophs)**ã€‚
    *   è¯±å¯¼æ¬¡ç”Ÿä»£è°¢äº§ç‰©ï¼ˆå¦‚ç”Ÿç‰©ç¢±ï¼‰å’Œé˜²å¾¡è›‹ç™½ï¼ˆå¦‚ç¡«å ‡ Thioninsï¼‰çš„åˆæˆã€‚
*   **ç”Ÿé•¿ä¸å‘è‚² (Development):**
    *   **ç”Ÿæ®–å‘è‚²ï¼š** è°ƒæ§èŠ±è¯è£‚å¼€ (Anther dehiscence) å’ŒèŠ±ç²‰æˆç†Ÿï¼ŒJAåˆæˆç¼ºé™·ä¼šå¯¼è‡´é›„æ€§ä¸è‚²ã€‚
    *   **æ ¹ç³»ï¼š** æŠ‘åˆ¶ä¸»æ ¹ç”Ÿé•¿ (Root growth inhibition)ã€‚
    *   **å…¶ä»–ï¼š** ä¿ƒè¿›è¡¨çš®æ¯› (Trichome) å½¢æˆã€è¯±å¯¼å¶ç‰‡è¡°è€ã€è°ƒæ§æ°”å­”å…³é—­ï¼ˆä¸ ABA ç±»ä¼¼ï¼‰ã€‚

**3. ä¿¡å·è½¬å¯¼æœºåˆ¶ (Signal Transduction)**
èŒ‰è‰é…¸ä¿¡å·è½¬å¯¼é‡‡ç”¨ä¸ç”Ÿé•¿ç´ ç›¸ä¼¼çš„ **"å»æŠ‘åˆ¶ (Derepression)"** æ¨¡å¼ï¼š
*   **æ—  JA æ—¶ (Off state):** JAZ é˜»éè›‹ç™½ä¸è½¬å½•å› å­ï¼ˆå¦‚ **MYC2**ï¼‰ç»“åˆï¼Œå¹¶æ‹›å‹Ÿå…±æŠ‘åˆ¶å› å­ï¼ˆNINJA, TPLï¼‰ï¼ŒæŠ‘åˆ¶ä¸‹æ¸¸æŠ—æ€§åŸºå› è¡¨è¾¾ã€‚
*   **æœ‰ JA æ—¶ (On state):**
    1.  **JA-Ile** ä½œä¸ºâ€œåˆ†å­èƒ¶æ°´â€ï¼Œä¿ƒè¿›å—ä½“ **COI1** ä¸ **JAZ** è›‹ç™½å½¢æˆé«˜äº²å’ŒåŠ›å¤åˆç‰©ã€‚
    2.  $SCF^{COI1}$ æ³›ç´ è¿æ¥é…¶å¯¹ JAZ è¿›è¡Œæ³›ç´ åŒ–æ ‡è®°ã€‚
    3.  **26S è›‹ç™½é…¶ä½“** é™è§£ JAZ è›‹ç™½ã€‚
    4.  è½¬å½•å› å­ **MYC2** è¢«é‡Šæ”¾ï¼Œå¯åŠ¨èŒ‰è‰é…¸å“åº”åŸºå› ï¼ˆå¦‚ *VSP*, *PDF1.2*ï¼‰çš„è½¬å½•ã€‚
![alt text](/Pic/æ¤ç‰©ç”Ÿç†å­¦/ååŠ/3.png)
---

### ä¸‰ã€ é‡ç‚¹å®éªŒä¸çªå˜ä½“æ¦‚è¿°

**3. JAZ è›‹ç™½é™è§£çš„å¯è§†åŒ–å®éªŒ**
*   **å®éªŒå†…å®¹ï¼š** æ„å»ºè¡¨è¾¾ *JAZ1-GUS* æˆ– *JAZ-GFP* èåˆè›‹ç™½çš„è½¬åŸºå› æ¤æ ªã€‚
*   **å¤„ç†ï¼š** æ–½åŠ  JA å¤„ç†ã€‚
*   **ç»“æœï¼š** å¯¹ç…§ç»„ä¸­æœ‰æ˜æ˜¾çš„ GUS æŸ“è‰²æˆ– GFP è§å…‰ï¼›JA å¤„ç†åï¼Œä¿¡å·è¿…é€Ÿæ¶ˆå¤±ã€‚è‹¥ä½¿ç”¨è›‹ç™½é…¶ä½“æŠ‘åˆ¶å‰‚å¤„ç†ï¼Œä¿¡å·åˆ™ä¸æ¶ˆå¤±ã€‚
*   **ç»“è®ºï¼š** ç›´è§‚è¯æ˜äº† JA è¯±å¯¼ JAZ è›‹ç™½é€šè¿‡ 26S è›‹ç™½é…¶ä½“é€”å¾„è¿…é€Ÿé™è§£ã€‚

---

### å››ã€ é—®é¢˜å›ç­” (Q&A)

åŸºäºææ–™æœ€åçš„ Summary éƒ¨åˆ†å›ç­”æ½œåœ¨é—®é¢˜ï¼š

**Q1: How are Jasmonates synthesized and metabolized? (èŒ‰è‰é…¸æ˜¯å¦‚ä½•åˆæˆä¸ä»£è°¢çš„ï¼Ÿ)**
**Answer:** èŒ‰è‰é…¸å±äºæ°§åŒ–è„‚ç±» (Oxylipins)ï¼Œæºäºè†œè„‚ä¸­æ¸¸ç¦»è„‚è‚ªé…¸çš„æ°§åŒ–ã€‚åˆæˆè·¨è¶Šä¸‰ä¸ªç»†èƒå™¨ï¼šè´¨ä½“ï¼ˆäºšéº»é…¸ $\rightarrow$ OPDAï¼‰ã€è¿‡æ°§åŒ–ç‰©é…¶ä½“ï¼ˆOPDA $\rightarrow$ JAï¼‰å’Œç»†èƒè´¨ï¼ˆJA $\rightarrow$ JA-Ileï¼‰ã€‚JA-Ile æ˜¯æ´»æ€§å½¢å¼ï¼ŒMeJA æ˜¯è¿è¾“å½¢å¼ã€‚JA-Ile æœ€ç»ˆè¢«ç»†èƒè‰²ç´  P450 (CYP94B3) æ°§åŒ–å¤±æ´»ã€‚

**Q2: What is the core mechanism of JA signaling? (JA ä¿¡å·è½¬å¯¼çš„æ ¸å¿ƒæœºåˆ¶æ˜¯ä»€ä¹ˆï¼Ÿ)**
**Answer:** æ ¸å¿ƒæ˜¯ **SCF-æ³›ç´ -è›‹ç™½é…¶ä½“é€”å¾„ä»‹å¯¼çš„å»æŠ‘åˆ¶æœºåˆ¶**ã€‚æ´»æ€§æ¿€ç´  JA-Ile ç»“åˆåˆ° $SCF^{COI1}$ å—ä½“å¤åˆç‰©å’Œ JAZ é˜»éè›‹ç™½ä¹‹é—´ï¼Œå¯¼è‡´ JAZ è¢«æ³›ç´ åŒ–å¹¶é™è§£ã€‚JAZ çš„é™è§£è§£é™¤äº†å…¶å¯¹è½¬å½•å› å­ MYC2 çš„æŠ‘åˆ¶ï¼Œä»è€Œæ¿€æ´»ä¸‹æ¸¸åŸºå› è¡¨è¾¾ã€‚


        </script>

        <footer class="article-footer">
            <p>&copy; 2025 Yukari502. All rights reserved.</p>
            <p class="disclaimer">Disclaimer: Portions of this content may be generated by AI. Please exercise
                discretion and verify information independently.</p>
        </footer>
    </div>

    <script src="../../script.js"></script>
</body>

</html>